Clinical Trials Browser

Phase 2/3 × Erlotinib Hydrochloride × 1 year × Clear all

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases